Literature DB >> 34789496

Temporal trends of carbon monoxide poisoning mortality at the global, regional and national levels: a cross-sectional study from the Global Burden of Disease study, 1990 and 2017.

Jianhai Long1, Yawei Sun2, Junxiu Zhao2, Jie Liu3, Xiaobo Peng4.   

Abstract

OBJECTIVES: Carbon monoxide (CO) poisoning is one of the most frequent causes of fatal poisoning worldwide. Few studies have explored the mortality trends of CO poisoning grouped by age and gender, at the regional, national and global levels. We therefore aimed to determine the pattern of CO poisoning mortality, as well as temporal trends at all levels.
DESIGN: A cross-sectional survey design was used in this study.
SETTING: CO poisoning data collected from the Global Burden of Diseases (GBDs), from 1990 to 2017, was arranged by sex, age, region and country. In addition, we used human development index data at the national level from the World Bank. PARTICIPANTS: We collected over 100 000 information on CO poisoning mortality between 1990 and 2017, derived from the GBD study in 2017. MAIN OUTCOMES AND MEASURES: We have calculated the estimated annual percentage changes in CO poisoning age-standardised mortality rate (ASR), by sex and age at different regions and countries to quantify the temporal trends in CO poisoning ASR.
RESULTS: Globally, death cases of CO poisoning decreased 7.2% from 38 210 in 1990 to 35 480 in 2017. The overall ASR decreased by an average of 1.83% (95% CI 2.10% to 1.56%) per year in this period. This decreasing pattern was heterogeneous across ages, regions and countries. The most pronounced decreases were generally observed in countries with a high sociodemographic index, including Estonia, South Korea and Puerto Rico.
CONCLUSIONS: Current prevention strategies should be reoriented, and much more targeted and specific strategies should be established in some countries to forestall CO poisoning. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epidemiology; public health; toxicology

Mesh:

Year:  2021        PMID: 34789496      PMCID: PMC8601087          DOI: 10.1136/bmjopen-2021-053240

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


Our study is the first to include regional, national and global levels extracted from Global Burden of Disease (GBD) study data. We presented temporal trends in carbon monoxide (CO) poisoning mortality by age and sex. This study analyses the secondary data of the GBD Study and hence it has all the limitations of the data. There may be an underestimation of individual CO poisoning aetiologies due to underdeveloped countries having poor quality and completeness of reporting on CO poisoning. This study informs the policymakers on further strategies to control CO poisoning mortality.

Introduction

Carbon monoxide (CO) is a colourless, odourless and tasteless non-irritant gas, making it imperceptible to human senses.1 Major non-occupational sources include poorly maintained or ventilated home heating systems, cooking appliances, motor vehicle exhaust and gasoline or other fuel-powered equipment (eg, portable generators and space heaters).2 The initial symptoms of CO poisoning are primarily nausea, fatigue, tachypnoea, headache, confusion and clumsiness,3 which are non-clinical effects that often lead to underdiagnosis or misdiagnosis of CO exposure.4 Exposure to CO is a serious health concern because individuals can be severely or fatally poisoned before even realising that they have been exposed.1 CO toxicity is one of the most common types of fatal poisoning in many countries.5 The underlying causes, prevention and treatment measures for CO poisoning have been extensively investigated in previous epidemiological studies.2 6–9 CO poisonings have been attributed to coal stoves used for heating, shower system water heaters, house or building fires, indoor charcoal barbecue use, disasters (eg, improper use of generators and charcoal grills after disasters, such as hurricanes1 10), exposure to exhaust during recreational boating,7 automobile exhaust gas and recreational boaters.8 Most incidents have occurred in residential settings.11 Reduced release of CO can be achieved through engineering innovations,12 such as the installation of catalytic converters in motor vehicles13 and the replacement of coal gas with natural gas.14–16 The installation of CO alarms can help prevent CO exposure,12 17 18 as well as appropriate public education.19 There are also several measures available to treat CO poisonings, such as hyperbaric oxygen therapy20 and advanced life support.21 Consequently, most countries have observed a decreasing CO poisoning mortality trend, for example in the USA22 and England.23 24 In contrast, a few countries, such as Iran23 and Belarus25 showed a stable and an increasing trend, respectively. Therefore, we hypothesised that the temporal trends of carbon monoxide poisoning mortality could be related to geography and economics26 at regional, national, and global levels. The Global Burden of Disease (GBD) study assessed the CO poisoning burden in 195 countries and territories and provided a unique opportunity to understand its landscape.27 In the current study, we retrieved detailed information on CO poisoning mortality grouped by age and sex from the GBD study 2017. We further assessed the disease burden of CO poisoning by determining temporal trends of CO poisoning mortality from 1990 to 2017 at regional, national and global levels and in relation to human characteristics. Our results can assist in the design of targeted strategies for CO poisoning prevention tailored to different countries.

Materials and methods

Study data

Annual deaths and age-standardised mortality rates (ASRs) for CO poisoning from 1990 to 2017 grouped by sex, age, region and country were collected from the GBD using the Global Health Data Exchange query tool (http://ghdx.healthdata.org/gbd-results-tool).27 The study design, metrics and analysis were published elsewhere.28 The CO poisoning mortality GBD 201728 study used data from over 100 000 sources covering the years between 1990 and 2017. Annual cases and age-standardised incidence rates for CO poisoning from 1990 to 2017 remain stable as online resource 1a in online supplemental file.28 According to sociodemographic index (SDI) data (online supplemental online resource 1b in online supplemental file),29 the 195 countries and territories in the GBD 201728 data were divided into five groups: low, low-middle, middle, high-middle and high SDI; and into 21 regions (online resource 1b in online supplemental file)30 according to their geographical location, such as East Asia, Central Europe, High-income North America, Oceania and Eastern Sub-Saharan Africa. The methods for GBD data extraction and disease burden estimation were based on Liu et al.31 Moreover, we collected and analysed the human development index (HDI) (online resource 1b in online supplemental file)32 and matched it with GBD data. This study used the data freely available from the Institute for Health Metrics and Evaluation (IHME)’s GBD database. Patients were not involved in the design, recruitment or conduct of the study.

Statistical analysis

We quantified CO poisoning death rate changes by estimating the annual percentage change (EAPC) from the ASRs.33 ASR trends can serve as a suitable surrogate for shifting patterns of disease within a population and providing insights into changing causal factors. The calculation methods for ASR and EAPC are given as below, according to Liu et al.31 ASR was considered increased when the EAPC34 35 value and its lower 95% CI boundary were >0, decreased when the EAPC value and its upper 95% CI boundary were both <0 and remained constant when the 95% CI of the EAPC value was 0. Additionally, to explore the factors influencing EAPC, we assessed the associations between EAPC and each ASR (1990) and HDI (2017) with quadratic prediction plots at the national level. Then, three groups of countries were selected for comparison from inside and outside the CI of the quadratic prediction plots. All data were analysed using the R software (V.3.5.1, Institute for Statistics and Mathematics) and STATA/MP (STATA V.13.1, Stata Corp). A p value <0.05 was considered statistically significant. ASR was defined as (per 100 000 population) following the direct method calculated by36: where summing up the products of the age-specific rates (α, where i denotes the ith age class) and the number of persons (or weight) (ω) in the same age subgroup i of the chosen reference standard population, then dividing the sum of standard population weights. The EAPC was defined by a summary and widely used measure of the ASR trend over a specified interval.37 A regression line was fitted to the natural logarithm of the rates: where y=ln (ASR) and x=calendar year. The EAPC was calculated as EAPC = and its 95% CI can also be obtained from the linear regression model. The HDI was defined as a composite index measuring average achievement in three basic dimensions of human development: a long and healthy life, knowledge and a decent standard of living. See Technical note 132 at http://hdr.undp.org/sites/default/files/hdr2018_technical_notes.pdf for details on how the HDI is calculated. The SDI was defined using log lag dependent income per capita, average educational attainment in the population over age 15, and total fertility rate. For detailed data of SDI and HDI see online supplemental table 1.

Results

Global CO poisoning burden

Table 1 shows the deaths and ASRs following CO poisoning from 1990 to 2017 and the changes that have occurred during this period. At a global level, the deaths decreased by 7.12%. The global ASR was 0.71 per 100 000 in 1990 and 0.46 per 100 000 in 2017, a decrease of 1.83 per year (95% CI 2.10 to 1.56) (table 1). Between the sexes, male mortality was higher at 26 320 deaths (68.9%) in 1990 and 23 730 (66.9%) in 2017 (figure 1A, B and table 1). The ASR decreased in both sexes, especially in males, for whom the EAPC was −2.02 (95% CI −2.35 to −1.70) (figure 1C and table 1). Across the age groups, the most deaths occurred between 15 and 49 years in 18 260 patients (47.8%) in 1990 and 14 630 patients (41.2%) in 2017 (figure 2A, B and table 1). As figure 2 shows, the proportion of deaths among individuals aged <50 years has decreased, whereas that among those aged >50 years has increased. Additionally, the ASR decreased in all age groups, except the >70-year group; children under 5 years experienced the largest decrease in EAPC of 3.77 (95% CI 3.90 to 3.64) (figure 2C and table 1).
Table 1

The death cases, age-standardised mortality and temporal trend of carbon monoxide poisoning from 1990 to 2017

Characteristics199020171990–2017
Deaths cases No.×103 (95% UI)ASR per 100 000 No. (95% UI)Deaths cases No.×103 (95% UI)ASR per 100 000 No. (95% UI)EAPC no. (95% CI)
Overall38.21 (33.65 to 46.93)0.71 (0.62 to 0.87)35.48 (25.7 to 38.82)0.46 (0.34 to 0.51)−1.83 (−2.10 to 1.56)
Sex
 Male26.32 (22.09 to 32.66)0.97 (0.81 to 1.2)23.73 (17.2 to 26.21)0.62 (0.45 to 0.68)−2.02 (−2.35 to 1.70)
 Female11.89 (10.33 to 15.43)0.44 (0.39 to 0.58)11.75 (7.53 to 13.05)0.31 (0.2 to 0.34)−1.38 (−1.54 to 1.22)
Age
 <5 years4.54 (3.49 to 5.54)0.70 (0.54 to 0.86)1.79 (1.25 to 2.21)0.26 (0.18 to 0.32)−3.77 (−3.90 to 3.64)
 5–14 years3.29 (2.48 to 4.49)0.29 (0.22 to 0.40)1.64 (1.07 to 1.93)0.13 (0.08 to 0.15)−3.63 (−3.98 to 3.28)
 15–49 years18.26 (15.98 to 22.68)0.67 (0.58 to 0.83)14.63 (11.11 to 15.90)0.37 (0.28 to 0.41)−3.33 (−3.88 to 2.78)
 50–69 years8.45 (7.88 to 9.97)1.23 (1.15 to 1.45)10.41 (7.67 to 11.33)0.79 (0.58 to 0.86)−1.99 (−2.36 to 1.62)
 ≥70 years3.66 (3.28 to 4.71)1.80 (1.61 to 2.32)7.02 (4.69 to 7.80)1.62 (1.08 to 1.80)0.00 (−0.24–0.24)
Socio to demographic index
 Low1.33 (0.84 to 1.75)0.19 (0.12 to 0.25)2.36 (1.7 to 2.91)0.18 (0.13 to 0.23)−0.06 (−0.12–0.00)
 Low to middle3.67 (2.48 to 4.38)0.35 (0.24 to 0.42)4.09 (2.66 to 4.67)0.24 (0.16 to 0.27)−1.49 (−1.56 to 1.43)
 Middle9.25 (7.4 to 13.73)0.6 (0.48 to 0.89)9.5 (5.3 to 11.03)0.45 (0.25 to 0.53)−1.05 (−1.11 to 1.00)
 Middle to high19.28 (17.88 to 22.61)1.73 (1.61 to 2.03)16.45 (12.99 to 18.01)1.19 (0.94 to 1.3)−1.92 (−2.45 to 1.38)
 High4.43 (4.3 to 4.67)0.46 (0.45 to 0.48)2.82 (2.74 to 3.03)0.25 (0.24 to 0.27)−2.00 (−2.28 to 1.71)
Region
 High to income Asia Pacific0.98 (0.92 to 1.06)0.57 (0.53 to 0.61)0.4 (0.38 to 0.42)0.22 (0.21 to 0.23)−2.74 (−3.48 to 1.99)
 Central Asia1.1 (1.02 to 1.14)1.57 (1.46 to 1.64)0.99 (0.9 to 1.17)1.09 (0.99 to 1.28)−0.57 (−1.08 to 0.06)
 East Asia14.24 (11.14 to 22.88)1.13 (0.89 to 1.82)14.82 (7.66 to 17.67)1.00 (0.52 to 1.19)−0.44 (−0.54 to 0.34)
 South Asia1.51 (1.03 to 1.84)0.14 (0.09 to 0.17)1.71 (1.26 to 1.98)0.1 (0.07 to 0.11)−1.22 (−1.34 to 1.10)
 Southeast Asia0.98 (0.6 to 1.21)0.21 (0.13 to 0.26)1.01 (0.56 to 1.24)0.15 (0.08 to 0.19)−1.29 (−1.37 to 1.20)
 Australasia0.03 (0.02 to 0.03)0.13 (0.12 to 0.14)0.03 (0.02 to 0.03)0.1 (0.09 to 0.11)−1.67 (−2.34 to 1.00)
 Caribbean0.13 (0.1 to 0.16)0.38 (0.29 to 0.47)0.09 (0.07 to 0.13)0.2 (0.15 to 0.27)−2.22 (−2.78 to 1.66)
 Central Europe1.77 (1.7 to 1.89)1.43 (1.37 to 1.52)0.75 (0.71 to 0.79)0.65 (0.62 to 0.68)−2.92 (−3.20 to 2.64)
 Eastern Europe10.89 (10.59 to 11.32)4.8 (4.67 to 4.99)7.74 (7.53 to 7.97)3.68 (3.58 to 3.79)−1.92 (−2.90 to 0.94)
 Western Europe1.25 (1.22 to 1.28)0.32 (0.32 to 0.33)0.59 (0.57 to 0.61)0.14 (0.13 to 0.14)−2.90 (−3.26 to 2.54)
 Andean Latin America0.13 (0.11 to 0.16)0.23 (0.17 to 0.28)0.09 (0.07 to 0.11)0.21 (0.18 to 0.26)−0.35 (−0.51 to 0.19)
 Central Latin America0.51 (0.49 to 0.53)0.31 (0.3 to 0.32)0.43 (0.4 to 0.44)0.17 (0.16 to 0.17)−2.42 (−2.58 to 2.27)
 Southern Latin America0.17 (0.16 to 0.19)0.35 (0.32 to 0.38)0.29 (0.26 to 0.32)0.44 (0.4 to 0.49)1.23 (0.67 to 1.80)
 Tropical Latin America0.2 (0.19 to 0.2)0.13 (0.12 to 0.13)0.13 (0.13 to 0.14)0.06 (0.06 to 0.06)−3.06 (−3.44 to 2.68)
 North Africa and Middle East2.34 (1.38 to 3.08)0.69 (0.4 to 0.9)2.99 (1.4 to 3.68)0.5 (0.23 to 0.61)−0.96 (−1.09 to 0.83)
 High to income North America0.87 (0.85 to 0.89)0.31 (0.3 to 0.32)1.12 (1.07 to 1.16)0.31 (0.3 to 0.32)0.64 (0.33 to 0.95)
 Oceania0.04 (0.02 to 0.06)0.63 (0.28 to 1)0.08 (0.04 to 0.13)0.67 (0.31 to 1.04)0.54 (0.39 to 0.69)
 Central Sub to Saharan Africa0.12 (0.07 to 0.18)0.21 (0.13 to 0.33)0.27 (0.19 to 0.46)0.23 (0.16 to 0.38)0.58 (0.36 to 0.80)
 Eastern Sub to Saharan Africa0.26 (0.19 to 0.38)0.14 (0.1 to 0.2)0.65 (0.48 to 0.86)0.17 (0.12 to 0.22)0.75 (0.59 to 0.90)
 Southern Sub to Saharan Africa0.14 (0.09 to 0.2)0.27 (0.17 to 0.38)0.18 (0.13 to 0.23)0.23 (0.17 to 0.3)−0.75 (−1.21 to 0.29)
 Western Sub to Saharan Africa0.59 (0.39 to 0.84)0.31 (0.2 to 0.44)1.09 (0.86 to 1.44)0.25 (0.2 to 0.33)−0.64 (−0.74 to 0.54)

ASR, age-standardised mortality rate; EAPC, estimated annual percentage change; UI, uncertainty interval.

Figure 1

Carbon monoxide (CO) poisoning mortality grouped by region and sex. (A) Proportion of CO poisoning deaths for each sex by region, in 1990 and 2017. (B) Numbers of CO poisoning deaths; the left column in each pair represents 1990 data and the right column 2017 data; the inset shows regions with low case report numbers reproduced at a different scale for clarity. (C) The estimated annual percentage change (EAPC) in the CO poisoning age-standardised mortality rate from 1990 to 2017, showing the EAPC for all cases and the larger of the sex changes for each region.

Figure 2

Carbon monoxide (CO) poisoning mortality grouped by region and age. (A) Proportion of CO poisoning deaths in 1990 and 2017. (B) Numbers of CO poisoning deaths in 1990 and 2017; the left column in each pair represents 1990 data and the right column 2017 data; the inset shows regions with low case report numbers reproduced at a different scale for clarity. (C) The estimated annual percentage change (EAPC) in the CO poisoning age-standardised mortality rate from 1990 to 2017, showing the EAPC for all cases and the largest of the age group changes for each region.

Carbon monoxide (CO) poisoning mortality grouped by region and sex. (A) Proportion of CO poisoning deaths for each sex by region, in 1990 and 2017. (B) Numbers of CO poisoning deaths; the left column in each pair represents 1990 data and the right column 2017 data; the inset shows regions with low case report numbers reproduced at a different scale for clarity. (C) The estimated annual percentage change (EAPC) in the CO poisoning age-standardised mortality rate from 1990 to 2017, showing the EAPC for all cases and the larger of the sex changes for each region. Carbon monoxide (CO) poisoning mortality grouped by region and age. (A) Proportion of CO poisoning deaths in 1990 and 2017. (B) Numbers of CO poisoning deaths in 1990 and 2017; the left column in each pair represents 1990 data and the right column 2017 data; the inset shows regions with low case report numbers reproduced at a different scale for clarity. (C) The estimated annual percentage change (EAPC) in the CO poisoning age-standardised mortality rate from 1990 to 2017, showing the EAPC for all cases and the largest of the age group changes for each region. The death cases, age-standardised mortality and temporal trend of carbon monoxide poisoning from 1990 to 2017 ASR, age-standardised mortality rate; EAPC, estimated annual percentage change; UI, uncertainty interval.

Regional CO poisoning burden

Table 1, figures 1 and 2 show the changes in deaths and ASRs due to CO poisoning between 1990 and 2017, grouped by sex and age and categorised by SDI level and geographical regions, respectively. Concerning SDI, deaths due to CO poisoning increased in areas with low, low-middle and middle scores and decreased in areas with high-middle and high scores. Surprisingly, the ASR decreased at all five SDI levels, especially in the areas with high SDI scores, which had an EAPC of −2.00 (95% CI −2.28 to −1.71) (table 1). In terms of sex, similar to the global trend, more than half of the patients with CO poisoning weremale. Moreover, the ASR decreased for male at all five SDI levels (figure 1A–C and online resource 2 in online supplemental file). Regarding age, the difference in proportion of deaths between 1990 and 2017 is that the second-highest proportion of deaths occurred in the <5-year group in 1990 and in the 50 to 69-year group in 2017 in low-scoring, low-middle-scoring and middle-scoring SDI regions, others producing the same distribution change as that seen globally (figure 2A and online resource 2 in online supplemental file). The ASR in regions with low, middle and high-middle SDI scores decreased the most in the <5-year group, with EAPCs of −0.63 (95% CI −0.70 to −0.57), −5.25 (95% CI −5.64 to −4.85) and −3.57 (95% CI −3.94 to −3.20), respectively. The largest ASR decrease in regions with low-middle and high SDI scores was in those aged 5–14 years (figure 2C and online resource 2 in online supplemental file). Surprisingly, contrary to global trends, deaths in the groups aged 50–69 and >70 years increased in regions with middle SDI scores, with EAPCs of 0.36 (95% CI 0.07 to 0.66) and 1.21 (95% CI 0.85 to 1.56), respectively (online resource 2 in online supplemental file). Geographical regions varied, with numbers of deaths in 2017 being higher in 11 regions, lower in 9 regions and stable in 1 region compared with those in 1990. The ASR decreased in 17 regions, increased in 3 regions and was stable in 1 region in the same comparison. Eastern Europe had the highest ASR in 2017, followed by Central Asia and East Asia. Sixteen of the 21 geographical regions demonstrated a negative EAPC; the greatest decrease was found in Tropical Latin America, with an EAPC of −3.06 (95% CI −3.44 to −2.68), followed by that in Central Europe. In contrast, the greatest ASR increase was found in Southern Latin America, with an EAPC of 1.23 (95% CI 0.67 to 1.80) (table 1). Sex analysis showed that male deaths comprised approximately 60% in 19 of the 21 geographical regions, except in Oceania (88.8%) and the Caribbean (only 47.2%) (figure 1A). In the 16 regions with a negative EAPC, 9 showed a more pronounced change for men; of the other 5 regions, 2 showed this pattern. In Oceania, males with EAPC of 0.60 (95% CI 0.43 to 0.76) showed that male ASR increased more than female (EAPC of 0.13, 95% CI 0.05 to 0.21), whereas in the Caribbean, males with EAPC of −3.51 (95% CI −4.20 to −2.82) showed that male ASR decreased much more than female (EAPC of −0.60, 95% CI −0.94 to −0.25) (figure 1C). Across the age groups, some regions differed from the global distribution, in which more than half of deaths were among those aged 15–69 years. In Western and Southern sub-Saharan Africa, the largest proportions of deaths occurred among those aged 15–49 and <5 years, respectively; in South Asia, the Caribbean, Western Europe and Tropical Latin America, deaths were the highest among those aged 15–49 and >70 years (figure 2A). Twelve regions had their greatest absolute EAPC among those aged <5 years, four among those aged 5–14 years, one among those aged 15–49 years, two among those aged 50–69 years and two aged >70 years. Two of these regions show the opposite. The high-income North American increased in ASR, while the pronounced change in the 50 to 69-year-old group with EAPC of −1.19 (95% CI −1.46 to −0.91). Central Asia’s ASR decreased, while the pronounced one is >70-year-old group with EAPC of 2.55 (95% CI 1.84 to 3.26) (figure 2C and online resource 2 in online supplemental file).

National CO poisoning burden

Figures 3 and 4 and online resources 3–13 in online supplemental file show changes in deaths and age-standardised mortality due to CO poisoning from 1990 to 2017 according to sex and age at the national level. China had the largest number of CO poisoning-related deaths in both 1990 (13 779) and 2017 (14 255), although the growth rate was only 3.46% (online resource 3 in online supplemental file). The UAE had the largest increase, with a growth rate of 625.26%. In contrast, Finland had the largest decrease, a reduction of 95.31% (figure 3B and online resource 3 in online supplemental file). The ASR varied greatly from country to country. Moldova had the highest ASR, at 4.68 per 100 000 in 2017, followed by the Russian Federation and Lithuania (figure 3A). The highest ASR in 1990 was also observed in the Russian Federation. The largest decrease in ASR was found in Estonia, at 9.76 per year (95% CI −10.43 to −9.08), followed by South Korea and Puerto Rico. In contrast, Mauritius had a substantial ASR increase of 6.27 per year (95% CI 4.75 to 7.82) (figure 3C and online resource 3 in online supplemental file). Of the 195 countries and territories, 129 demonstrated a decrease, 49 an increase and 17 a constant trend in ASR from 1990 to 2017 (online resource 3 in online supplemental file). For sex, most trends were consistent with those at the national level. Moldova had the highest ASR at 2.47 per 100 000 in females and 7.10 per 100 000 in males (online resources 4, 7A and 8A in online supplemental file). Bangladesh and the UAE had the largest increase in female and male CO poisoning-related deaths, respectively (online resources 4, 7B and 8B in online supplemental file). The highest EAPC for females was found in Thailand, at 7.93 (95% CI 6.73 to 9.15). In contrast, the lowest EAPC for females was observed in South Korea, at −8.80 (95% CI −10.41 to −7.13) (online resources 4 and 7C in online supplemental file). Moldova had the largest ASR increase for males, and Finland had the largest decrease (online resources 4 and 8C in online supplemental file). Considering age, most trends were again consistent with those at the national level. Moldova had the highest ASR in <5 years (1.82 per 100 000), 5–14 years (526.34%), 15–49 years, 50–70 years (8.19 per 100 000) and >70 years (12.86 per 100 000). Russia had the highest ASR in 5–14 years (0.66 per 100 000) and 15–49 years (3.56 per 100 000) (online resources 5, 9A, 10A, 11A, 12A and 13A in online supplemental file). Thailand, Bangladesh and Turkey had the largest increase in deaths among individuals aged <5 years (306.95%), 5–14 years (526.34%) and >70 years (532.83%), respectively. In contrast, Estonia and South Korea reported the greatest decrease among individuals aged <5 years and 5–14 years, respectively (online resources 5. 9B, 10B, 11B, 12B and 13B in online supplemental file). South Korea also reported the lowest EAPCs among individuals aged <5 years and 15–49 years; in addition, Bermuda observed this change in those aged 5–14 years. In contrast, the largest EAPCs were observed among individuals aged 5–14 and >70 years in Kazakhstan and 15–49 years in Thailand (online resources 5, 9C, 10C, 11C, 12C and 13C in online supplemental file).
Figure 3

The global disease burden of carbon monoxide (CO) poisoning in 195 countries and territories. (A) The age-standardised mortality rate (ASR) for CO poisoning in 2017. (B) The percentage change in CO poisoning deaths between 1990 and 2017. (C) The estimated annual percentage change (EAPC) in the CO poisoning ASR from 1990 to 2017.

The global disease burden of carbon monoxide (CO) poisoning in 195 countries and territories. (A) The age-standardised mortality rate (ASR) for CO poisoning in 2017. (B) The percentage change in CO poisoning deaths between 1990 and 2017. (C) The estimated annual percentage change (EAPC) in the CO poisoning ASR from 1990 to 2017. Correlations between estimated annual percentage change (EAPC) and (A) the carbon monoxide (CO) poisoning age-standardised mortality rate (ASR) in 1990, and (B) human development index (HDI) in 2017; the circles represent countries with available HDI data, and their size indicates the number of death cases. As shown in figure 4, ASR (in 1990) and HDI (in 2017) were significantly associated with EAPC. The ASR related to CO poisoning in 1990 reflects the CO poisoning at baseline, and the HDI in 2017 can serve as a surrogate for the level and availability of healthcare in each country. A significant negative association was found between EAPC and ASR (r=−0.365, p<0.001) when the ASR was limited to less than 2.816 per 100 000. In contrast, when the ASR was above 2.816 per 100 000, the association disappeared, such as in Moldova, Estonia and Finland (online resource 6 in online supplemental file). Additionally, a significant negative relationship was detected between EAPC and HDI (r=−0.356, p<0.001). Countries with a higher HDI have experienced a more rapid decrease in their CO poisoning ASRs between 1990 and 2017.
Figure 4

Correlations between estimated annual percentage change (EAPC) and (A) the carbon monoxide (CO) poisoning age-standardised mortality rate (ASR) in 1990, and (B) human development index (HDI) in 2017; the circles represent countries with available HDI data, and their size indicates the number of death cases.

Discussion

CO poisoning is one of the most common types of fatal poisoning worldwide.3 12 In the current study, we comprehensively analysed temporal changes in CO poisoning deaths grouped by age and sex at, regional, national and global levels. In general, CO poisoning mortality reduced between 1990 and 2017.38 A sex-based disparity was present, with male ASR and deaths being almost twice as high as females.11 12 Males may experience greater CO exposure as they more frequently use CO-emitting equipment,12 39 causing higher mortality.7 11 Additionally, females have an advantage over males in terms of the severity of poisoning and subsequent prognosis; they may be more likely to visit the emergency department earlier (and thus receive treatment that prevents death) and manifest symptoms of CO poisoning earlier due to their smaller size and lower red blood cell count.2 Across age groups, the largest percentage of global CO poisoning deaths occurred among those aged 15–49 years; the percentage of such deaths decreased in the <50-year group and increased in the >50-year group, which is related to ageing populations.40 The highest CO poisoning ASRs were seen among individuals aged >70 years.3 Elderly people may have comorbidities with cardiopulmonary disease41 and can easily be misdiagnosed,42 which leads to higher hospitalisation2 and death rates in this population.43 However, the heterogeneous pattern observed across region, nation and population characteristics results in markedly diverse CO poisoning mortalities globally and makes the prevention of CO poisoning complex.26 For example, the increasing ASR in Southern Latin America is most pronounced, as measured by EAPC, among females and those aged >70 years. This is quite unlike the situation in the Caribbean, which has a decreasing ASR that is most pronounced in males and those <5 years old.

Regional differences in CO poisoning mortality distribution

Economics and geography determine individual susceptibility to CO poisoning.26 EAPC values tended to decrease with increasing SDI scores. This implies that a high value of SDI, which combines low-rate total fertility, average to high educational attainment in the population over age 15,44 and high income per capita,17 23 could reduce CO poisoning fatalities. CO poisoning has been reported to be the most frequent cause of fatal poisoning in children, infants and fetuses,3 which may explain reductions in ASR consequent on low-rate total fertility. Considering geographical regions, the CO poisoning ASRs in Central and Eastern Sub-Saharan Africa, Southern Latin America, and high-income North America demonstrated an increasing trend. In contrast, a decline in ASR was present in the remaining 16 regions, such as Tropical Latin America, Europe and the Caribbean. Most regions with ASR increases38 were located between 40°S and 40°N, which have more than half of the countries with low to middle SDI scores, indicating low economic and healthcare levels.45

National differences in CO poisoning mortality distribution

The level of CO exposure is closely related to socioeconomic status, education, medical level and national policies. HDI and EAPC were found to be negatively correlated, which means that long and healthy life, adequate education,11 and a high per capita gross domestic product46 induce a decline in ASR. Similarly to SDI scores, the major causes of CO poisonings consist of non-standardised traditional heating systems commonly used in countries with low socioeconomic status.47 Additionally, ASR in 1990 (baseline) had a significant negative association with EAPC when the ASR was limited to below 2.816 per 100 000. This means that the worse the initial CO poisoning situation, the more impact CO poisoning prevention measures will have. Three groups of countries were selected for detailed comparison: conforming to the fit curve (USA), higher than the fit curve (Moldova, Lithuania) and lower than the fit curve (Estonia) (online supplemental online resource 6). These four countries showed ageing trends, which did not differ significantly between each other in population proportion, sex ratio and age composition. Interestingly, excluding economic effects, promulgation and compliance with ordinances have become the main factors influencing EAPCs. For example, Estonia had the lowest national EAPC following mandatory fitting of automatic fire alarm systems (smoke alarms) at homes.48 Conversely, although some states of the USA have also issued corresponding regulations, only 30%–50% compliance has been observed49 because a low initial ASR caused low-risk perception; this resulted in an increasing ASR. Consequently, it is recommended that countries with both high ASR and middle-to-high SDI scores, such as Moldova and Lithuania, issue laws that require the installation of CO detectors in residences16 and enhance education and publicity, which will improve public health49 and economic performance.17

Differences in population characteristics should also guide prevention measures

In relation to sex, male deaths in Oceania were exceptionally high (88.8%) and in the Caribbean exceptionally low (47.2%) compared with approximately 60% in the remaining 19 geographical regions. Development of fishing has a higher risk of CO fatality largely because of the need for portable heating sources, work in confined spaces (eg, boat cabin, water holding tanks) and remote locations far from medical care, and often solitary work.39 Fisheries are a major industry in Oceania,50 which leads to a fivefold higher mortality rate for men than women.39 In contrast, the Caribbean has prospered through tourism,51 leading to a huge drop in male mortality. Consequently, it is important to reduce the mortality of CO poisoning by transforming the occupational composition ratio and preventing occupational CO poisoning.39 In terms of age, all regions showed proportions of CO poisoning-induced deaths decreasing in the under-50s and increasing in the over-50s, which was consistent with global trends. The most pronounced EAPC observed was the decline in the under-5s in more than half of the geographical regions. However, the EAPC was positive in Eastern Sub-Saharan Africa, most pronounced in the under-5s, where this age group comprises 15.81% of the population.52 The overall EAPC is negative in Central Asia, while its most pronounced age-stratified EAPC is a positive value for the over-70s. Examples include Mongolia, Uzbekistan and Thailand, consistent with the increasing trend in this age group in areas with middle SDI scores. Projections of ageing in populations indicate that in 2050, 80% of older people will be living in low-income and middle-income countries.40 Although the GBD estimates fill a gap where actual data on disease burden are sparse or unavailable, several limitations should be noted. First, the accuracy and robustness of GBD estimates largely depend on the quality and quantity of data used in the modelling. For example, the misdiagnosis of CO poisoning as influenza, gastroenteritis or infantile colic2 3 and the under-reporting of CO poisoning,53 affect GBD data quality. Second, there may be an underestimation of individual CO poisoning aetiologies, such as coal stoves used for heating, shower system water heaters, or building or house fires, owing to a lack of relevant information. Consequently, these variables were not assessed in the current study. The quality and completeness of reporting issues may be more likely to occur in underdeveloped countries, which may account for unexpectedly low rates of mortality than found in developed countries where surveillance tools to support the accuracy of data may be more readily available. In summary, CO poisoning remains a major global public health concern.14 Although we have achieved great success in its prevention and treatment across the world, high ASRs and EAPCs were observed in most low-SDI scoring countries and a few with middle-to-high scores. This indicates the necessity for laws mandating CO alarm installation and CO poisoning awareness campaigns (eg, media reports, community health fairs, free alarm distribution and educational materials). Moreover, workers training on CO poisoning and innovation and improvement in workplace technology could reduce occupational CO poisoning deaths. CO poisoning in the elderly is a global health concern that cannot be ignored. More attention should be paid to the elderly in middle-income countries using interventions, such as developing systems for providing long-term care that collaborates across sectors and levels of government.54
  46 in total

1.  Carbon monoxide poisoning.

Authors:  E Walker; A Hay
Journal:  BMJ       Date:  1999-10-23

2.  Risk and protective factors for fires, burns, and carbon monoxide poisoning in U.S. households.

Authors:  Carol W Runyan; Renee M Johnson; Jingzhen Yang; Anna E Waller; David Perkis; Stephen W Marshall; Tamera Coyne-Beasley; Kara S McGee
Journal:  Am J Prev Med       Date:  2005-01       Impact factor: 5.043

3.  Extracorporeal Membrane Oxygenation (ECMO) for Severe Toxicological Exposures: Review of the Toxicology Investigators Consortium (ToxIC).

Authors:  G S Wang; R Levitan; T J Wiegand; J Lowry; R F Schult; S Yin
Journal:  J Med Toxicol       Date:  2016-03

4.  Hospital burden of unintentional carbon monoxide poisoning in the United States, 2007.

Authors:  Shahed Iqbal; Huay-Zong Law; Jacquelyn H Clower; Fuyuen Y Yip; Anne Elixhauser
Journal:  Am J Emerg Med       Date:  2011-05-12       Impact factor: 2.469

Review 5.  Review of unintentional non-fire-related carbon monoxide poisoning morbidity and mortality in Florida, 1999-2007.

Authors:  Laurel Harduar-Morano; Sharon Watkins
Journal:  Public Health Rep       Date:  2011 Mar-Apr       Impact factor: 2.792

6.  Economic implications of unintentional carbon monoxide poisoning in the United States and the cost and benefit of CO detectors.

Authors:  Tao Ran; Tursynbek Nurmagambetov; Kanta Sircar
Journal:  Am J Emerg Med       Date:  2017-08-23       Impact factor: 2.469

7.  Carbon monoxide-related deaths in Ankara between 2001 and 2011.

Authors:  Cem Uysal; Safa Celik; Aynur Duzgun Altuntas; Eyup Kandemir; Mehmet Kaya; Mustafa Karapirli; Sevilay Sezer; Omer Akyol
Journal:  Inhal Toxicol       Date:  2013-02       Impact factor: 2.724

Review 8.  Epidemiology, pathophysiology, clinical evaluation, and treatment of carbon monoxide poisoning in child, infant, and fetus.

Authors:  Atilla Alp Gozubuyuk; Huseyin Dag; Alper Kacar; Yakup Karakurt; Vefik Arica
Journal:  North Clin Istanb       Date:  2017-05-10

9.  Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016.

Authors: 
Journal:  Lancet       Date:  2018-06-01       Impact factor: 202.731

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Degu Abate; Naghmeh Abbasi; Hedayat Abbastabar; Foad Abd-Allah; Omar Abdel-Rahman; Ahmed Abdelalim; Amir Abdoli; Ibrahim Abdollahpour; Abdishakur S M Abdulle; Nebiyu Dereje Abebe; Haftom Niguse Abraha; Laith Jamal Abu-Raddad; Ahmed Abualhasan; Isaac Akinkunmi Adedeji; Shailesh M Advani; Mohsen Afarideh; Mahdi Afshari; Mohammad Aghaali; Dominic Agius; Sutapa Agrawal; Ayat Ahmadi; Elham Ahmadian; Ehsan Ahmadpour; Muktar Beshir Ahmed; Mohammad Esmaeil Akbari; Tomi Akinyemiju; Ziyad Al-Aly; Assim M AlAbdulKader; Fares Alahdab; Tahiya Alam; Genet Melak Alamene; Birhan Tamene T Alemnew; Kefyalew Addis Alene; Cyrus Alinia; Vahid Alipour; Syed Mohamed Aljunid; Fatemeh Allah Bakeshei; Majid Abdulrahman Hamad Almadi; Amir Almasi-Hashiani; Ubai Alsharif; Shirina Alsowaidi; Nelson Alvis-Guzman; Erfan Amini; Saeed Amini; Yaw Ampem Amoako; Zohreh Anbari; Nahla Hamed Anber; Catalina Liliana Andrei; Mina Anjomshoa; Fereshteh Ansari; Ansariadi Ansariadi; Seth Christopher Yaw Appiah; Morteza Arab-Zozani; Jalal Arabloo; Zohreh Arefi; Olatunde Aremu; Habtamu Abera Areri; Al Artaman; Hamid Asayesh; Ephrem Tsegay Asfaw; Alebachew Fasil Ashagre; Reza Assadi; Bahar Ataeinia; Hagos Tasew Atalay; Zerihun Ataro; Suleman Atique; Marcel Ausloos; Leticia Avila-Burgos; Euripide F G A Avokpaho; Ashish Awasthi; Nefsu Awoke; Beatriz Paulina Ayala Quintanilla; Martin Amogre Ayanore; Henok Tadesse Ayele; Ebrahim Babaee; Umar Bacha; Alaa Badawi; Mojtaba Bagherzadeh; Eleni Bagli; Senthilkumar Balakrishnan; Abbas Balouchi; Till Winfried Bärnighausen; Robert J Battista; Masoud Behzadifar; Meysam Behzadifar; Bayu Begashaw Bekele; Yared Belete Belay; Yaschilal Muche Belayneh; Kathleen Kim Sachiko Berfield; Adugnaw Berhane; Eduardo Bernabe; Mircea Beuran; Nickhill Bhakta; Krittika Bhattacharyya; Belete Biadgo; Ali Bijani; Muhammad Shahdaat Bin Sayeed; Charles Birungi; Catherine Bisignano; Helen Bitew; Tone Bjørge; Archie Bleyer; Kassawmar Angaw Bogale; Hunduma Amensisa Bojia; Antonio M Borzì; Cristina Bosetti; Ibrahim R Bou-Orm; Hermann Brenner; Jerry D Brewer; Andrey Nikolaevich Briko; Nikolay Ivanovich Briko; Maria Teresa Bustamante-Teixeira; Zahid A Butt; Giulia Carreras; Juan J Carrero; Félix Carvalho; Clara Castro; Franz Castro; Ferrán Catalá-López; Ester Cerin; Yazan Chaiah; Wagaye Fentahun Chanie; Vijay Kumar Chattu; Pankaj Chaturvedi; Neelima Singh Chauhan; Mohammad Chehrazi; Peggy Pei-Chia Chiang; Tesfaye Yitna Chichiabellu; Onyema Greg Chido-Amajuoyi; Odgerel Chimed-Ochir; Jee-Young J Choi; Devasahayam J Christopher; Dinh-Toi Chu; Maria-Magdalena Constantin; Vera M Costa; Emanuele Crocetti; Christopher Stephen Crowe; Maria Paula Curado; Saad M A Dahlawi; Giovanni Damiani; Amira Hamed Darwish; Ahmad Daryani; José das Neves; Feleke Mekonnen Demeke; Asmamaw Bizuneh Demis; Birhanu Wondimeneh Demissie; Gebre Teklemariam Demoz; Edgar Denova-Gutiérrez; Afshin Derakhshani; Kalkidan Solomon Deribe; Rupak Desai; Beruk Berhanu Desalegn; Melaku Desta; Subhojit Dey; Samath Dhamminda Dharmaratne; Meghnath Dhimal; Daniel Diaz; Mesfin Tadese Tadese Dinberu; Shirin Djalalinia; David Teye Doku; Thomas M Drake; Manisha Dubey; Eleonora Dubljanin; Eyasu Ejeta Duken; Hedyeh Ebrahimi; Andem Effiong; Aziz Eftekhari; Iman El Sayed; Maysaa El Sayed Zaki; Shaimaa I El-Jaafary; Ziad El-Khatib; Demelash Abewa Elemineh; Hajer Elkout; Richard G Ellenbogen; Aisha Elsharkawy; Mohammad Hassan Emamian; Daniel Adane Endalew; Aman Yesuf Endries; Babak Eshrati; Ibtihal Fadhil; Vahid Fallah Omrani; Mahbobeh Faramarzi; Mahdieh Abbasalizad Farhangi; Andrea Farioli; Farshad Farzadfar; Netsanet Fentahun; Eduarda Fernandes; Garumma Tolu Feyissa; Irina Filip; Florian Fischer; James L Fisher; Lisa M Force; Masoud Foroutan; Marisa Freitas; Takeshi Fukumoto; Neal D Futran; Silvano Gallus; Fortune Gbetoho Gankpe; Reta Tsegaye Gayesa; Tsegaye Tewelde Gebrehiwot; Gebreamlak Gebremedhn Gebremeskel; Getnet Azeze Gedefaw; Belayneh K Gelaw; Birhanu Geta; Sefonias Getachew; Kebede Embaye Gezae; Mansour Ghafourifard; Alireza Ghajar; Ahmad Ghashghaee; Asadollah Gholamian; Paramjit Singh Gill; Themba T G Ginindza; Alem Girmay; Muluken Gizaw; Ricardo Santiago Gomez; Sameer Vali Gopalani; Giuseppe Gorini; Bárbara Niegia Garcia Goulart; Ayman Grada; Maximiliano Ribeiro Guerra; Andre Luiz Sena Guimaraes; Prakash C Gupta; Rahul Gupta; Kishor Hadkhale; Arvin Haj-Mirzaian; Arya Haj-Mirzaian; Randah R Hamadeh; Samer Hamidi; Lolemo Kelbiso Hanfore; Josep Maria Haro; Milad Hasankhani; Amir Hasanzadeh; Hamid Yimam Hassen; Roderick J Hay; Simon I Hay; Andualem Henok; Nathaniel J Henry; Claudiu Herteliu; Hagos D Hidru; Chi Linh Hoang; Michael K Hole; Praveen Hoogar; Nobuyuki Horita; H Dean Hosgood; Mostafa Hosseini; Mehdi Hosseinzadeh; Mihaela Hostiuc; Sorin Hostiuc; Mowafa Househ; Mohammedaman Mama Hussen; Bogdan Ileanu; Milena D Ilic; Kaire Innos; Seyed Sina Naghibi Irvani; Kufre Robert Iseh; Sheikh Mohammed Shariful Islam; Farhad Islami; Nader Jafari Balalami; Morteza Jafarinia; Leila Jahangiry; Mohammad Ali Jahani; Nader Jahanmehr; Mihajlo Jakovljevic; Spencer L James; Mehdi Javanbakht; Sudha Jayaraman; Sun Ha Jee; Ensiyeh Jenabi; Ravi Prakash Jha; Jost B Jonas; Jitendra Jonnagaddala; Tamas Joo; Suresh Banayya Jungari; Mikk Jürisson; Ali Kabir; Farin Kamangar; André Karch; Narges Karimi; Ansar Karimian; Amir Kasaeian; Gebremicheal Gebreslassie Kasahun; Belete Kassa; Tesfaye Dessale Kassa; Mesfin Wudu Kassaw; Anil Kaul; Peter Njenga Keiyoro; Abraham Getachew Kelbore; Amene Abebe Kerbo; Yousef Saleh Khader; Maryam Khalilarjmandi; Ejaz Ahmad Khan; Gulfaraz Khan; Young-Ho Khang; Khaled Khatab; Amir Khater; Maryam Khayamzadeh; Maryam Khazaee-Pool; Salman Khazaei; Abdullah T Khoja; Mohammad Hossein Khosravi; Jagdish Khubchandani; Neda Kianipour; Daniel Kim; Yun Jin Kim; Adnan Kisa; Sezer Kisa; Katarzyna Kissimova-Skarbek; Hamidreza Komaki; Ai Koyanagi; Kristopher J Krohn; Burcu Kucuk Bicer; Nuworza Kugbey; Vivek Kumar; Desmond Kuupiel; Carlo La Vecchia; Deepesh P Lad; Eyasu Alem Lake; Ayenew Molla Lakew; Dharmesh Kumar Lal; Faris Hasan Lami; Qing Lan; Savita Lasrado; Paolo Lauriola; Jeffrey V Lazarus; James Leigh; Cheru Tesema Leshargie; Yu Liao; Miteku Andualem Limenih; Stefan Listl; Alan D Lopez; Platon D Lopukhov; Raimundas Lunevicius; Mohammed Madadin; Sameh Magdeldin; Hassan Magdy Abd El Razek; Azeem Majeed; Afshin Maleki; Reza Malekzadeh; Ali Manafi; Navid Manafi; Wondimu Ayele Manamo; Morteza Mansourian; Mohammad Ali Mansournia; Lorenzo Giovanni Mantovani; Saman Maroufizadeh; Santi Martini S Martini; Tivani Phosa Mashamba-Thompson; Benjamin Ballard Massenburg; Motswadi Titus Maswabi; Manu Raj Mathur; Colm McAlinden; Martin McKee; Hailemariam Abiy Alemu Meheretu; Ravi Mehrotra; Varshil Mehta; Toni Meier; Yohannes A Melaku; Gebrekiros Gebremichael Meles; Hagazi Gebre Meles; Addisu Melese; Mulugeta Melku; Peter T N Memiah; Walter Mendoza; Ritesh G Menezes; Shahin Merat; Tuomo J Meretoja; Tomislav Mestrovic; Bartosz Miazgowski; Tomasz Miazgowski; Kebadnew Mulatu M Mihretie; Ted R Miller; Edward J Mills; Seyed Mostafa Mir; Hamed Mirzaei; Hamid Reza Mirzaei; Rashmi Mishra; Babak Moazen; Dara K Mohammad; Karzan Abdulmuhsin Mohammad; Yousef Mohammad; Aso Mohammad Darwesh; Abolfazl Mohammadbeigi; Hiwa Mohammadi; Moslem Mohammadi; Mahdi Mohammadian; Abdollah Mohammadian-Hafshejani; Milad Mohammadoo-Khorasani; Reza Mohammadpourhodki; Ammas Siraj Mohammed; Jemal Abdu Mohammed; Shafiu Mohammed; Farnam Mohebi; Ali H Mokdad; Lorenzo Monasta; Yoshan Moodley; Mahmood Moosazadeh; Maryam Moossavi; Ghobad Moradi; Mohammad Moradi-Joo; Maziar Moradi-Lakeh; Farhad Moradpour; Lidia Morawska; Joana Morgado-da-Costa; Naho Morisaki; Shane Douglas Morrison; Abbas Mosapour; Seyyed Meysam Mousavi; Achenef Asmamaw Muche; Oumer Sada S Muhammed; Jonah Musa; Ashraf F Nabhan; Mehdi Naderi; Ahamarshan Jayaraman Nagarajan; Gabriele Nagel; Azin Nahvijou; Gurudatta Naik; Farid Najafi; Luigi Naldi; Hae Sung Nam; Naser Nasiri; Javad Nazari; Ionut Negoi; Subas Neupane; Polly A Newcomb; Haruna Asura Nggada; Josephine W Ngunjiri; Cuong Tat Nguyen; Leila Nikniaz; Dina Nur Anggraini Ningrum; Yirga Legesse Nirayo; Molly R Nixon; Chukwudi A Nnaji; Marzieh Nojomi; Shirin Nosratnejad; Malihe Nourollahpour Shiadeh; Mohammed Suleiman Obsa; Richard Ofori-Asenso; Felix Akpojene Ogbo; In-Hwan Oh; Andrew T Olagunju; Tinuke O Olagunju; Mojisola Morenike Oluwasanu; Abidemi E Omonisi; Obinna E Onwujekwe; Anu Mary Oommen; Eyal Oren; Doris D V Ortega-Altamirano; Erika Ota; Stanislav S Otstavnov; Mayowa Ojo Owolabi; Mahesh P A; Jagadish Rao Padubidri; Smita Pakhale; Amir H Pakpour; Adrian Pana; Eun-Kee Park; Hadi Parsian; Tahereh Pashaei; Shanti Patel; Snehal T Patil; Alyssa Pennini; David M Pereira; Cristiano Piccinelli; Julian David Pillay; Majid Pirestani; Farhad Pishgar; Maarten J Postma; Hadi Pourjafar; Farshad Pourmalek; Akram Pourshams; Swayam Prakash; Narayan Prasad; Mostafa Qorbani; Mohammad Rabiee; Navid Rabiee; Amir Radfar; Alireza Rafiei; Fakher Rahim; Mahdi Rahimi; Muhammad Aziz Rahman; Fatemeh Rajati; Saleem M Rana; Samira Raoofi; Goura Kishor Rath; David Laith Rawaf; Salman Rawaf; Robert C Reiner; Andre M N Renzaho; Nima Rezaei; Aziz Rezapour; Ana Isabel Ribeiro; Daniela Ribeiro; Luca Ronfani; Elias Merdassa Roro; Gholamreza Roshandel; Ali Rostami; Ragy Safwat Saad; Parisa Sabbagh; Siamak Sabour; Basema Saddik; Saeid Safiri; Amirhossein Sahebkar; Mohammad Reza Salahshoor; Farkhonde Salehi; Hosni Salem; Marwa Rashad Salem; Hamideh Salimzadeh; Joshua A Salomon; Abdallah M Samy; Juan Sanabria; Milena M Santric Milicevic; Benn Sartorius; Arash Sarveazad; Brijesh Sathian; Maheswar Satpathy; Miloje Savic; Monika Sawhney; Mehdi Sayyah; Ione J C Schneider; Ben Schöttker; Mario Sekerija; Sadaf G Sepanlou; Masood Sepehrimanesh; Seyedmojtaba Seyedmousavi; Faramarz Shaahmadi; Hosein Shabaninejad; Mohammad Shahbaz; Masood Ali Shaikh; Amir Shamshirian; Morteza Shamsizadeh; Heidar Sharafi; Zeinab Sharafi; Mehdi Sharif; Ali Sharifi; Hamid Sharifi; Rajesh Sharma; Aziz Sheikh; Reza Shirkoohi; Sharvari Rahul Shukla; Si Si; Soraya Siabani; Diego Augusto Santos Silva; Dayane Gabriele Alves Silveira; Ambrish Singh; Jasvinder A Singh; Solomon Sisay; Freddy Sitas; Eugène Sobngwi; Moslem Soofi; Joan B Soriano; Vasiliki Stathopoulou; Mu'awiyyah Babale Sufiyan; Rafael Tabarés-Seisdedos; Takahiro Tabuchi; Ken Takahashi; Omid Reza Tamtaji; Mohammed Rasoul Tarawneh; Segen Gebremeskel Tassew; Parvaneh Taymoori; Arash Tehrani-Banihashemi; Mohamad-Hani Temsah; Omar Temsah; Berhe Etsay Tesfay; Fisaha Haile Tesfay; Manaye Yihune Teshale; Gizachew Assefa Tessema; Subash Thapa; Kenean Getaneh Tlaye; Roman Topor-Madry; Marcos Roberto Tovani-Palone; Eugenio Traini; Bach Xuan Tran; Khanh Bao Tran; Afewerki Gebremeskel Tsadik; Irfan Ullah; Olalekan A Uthman; Marco Vacante; Maryam Vaezi; Patricia Varona Pérez; Yousef Veisani; Simone Vidale; Francesco S Violante; Vasily Vlassov; Stein Emil Vollset; Theo Vos; Kia Vosoughi; Giang Thu Vu; Isidora S Vujcic; Henry Wabinga; Tesfahun Mulatu Wachamo; Fasil Shiferaw Wagnew; Yasir Waheed; Fitsum Weldegebreal; Girmay Teklay Weldesamuel; Tissa Wijeratne; Dawit Zewdu Wondafrash; Tewodros Eshete Wonde; Adam Belay Wondmieneh; Hailemariam Mekonnen Workie; Rajaram Yadav; Abbas Yadegar; Ali Yadollahpour; Mehdi Yaseri; Vahid Yazdi-Feyzabadi; Alex Yeshaneh; Mohammed Ahmed Yimam; Ebrahim M Yimer; Engida Yisma; Naohiro Yonemoto; Mustafa Z Younis; Bahman Yousefi; Mahmoud Yousefifard; Chuanhua Yu; Erfan Zabeh; Vesna Zadnik; Telma Zahirian Moghadam; Zoubida Zaidi; Mohammad Zamani; Hamed Zandian; Alireza Zangeneh; Leila Zaki; Kazem Zendehdel; Zerihun Menlkalew Zenebe; Taye Abuhay Zewale; Arash Ziapour; Sanjay Zodpey; Christopher J L Murray
Journal:  JAMA Oncol       Date:  2019-12-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.